nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Vinorelbine—ovarian cancer	0.0958	0.212	CbGbCtD
Perhexiline—CYP3A4—Topotecan—ovarian cancer	0.0865	0.192	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—ovarian cancer	0.0751	0.166	CbGbCtD
Perhexiline—CYP3A4—Vinorelbine—ovarian cancer	0.0609	0.135	CbGbCtD
Perhexiline—CYP3A4—Paclitaxel—ovarian cancer	0.0428	0.0948	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—ovarian cancer	0.0363	0.0804	CbGbCtD
Perhexiline—CYP3A4—Docetaxel—ovarian cancer	0.0309	0.0686	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—ovarian cancer	0.0231	0.0511	CbGbCtD
Perhexiline—CPT2—myometrium—ovarian cancer	0.0171	0.0847	CbGeAlD
Perhexiline—CPT2—uterine cervix—ovarian cancer	0.0133	0.0659	CbGeAlD
Perhexiline—CPT2—decidua—ovarian cancer	0.0127	0.0628	CbGeAlD
Perhexiline—CPT2—endometrium—ovarian cancer	0.0121	0.0596	CbGeAlD
Perhexiline—CPT1A—gonad—ovarian cancer	0.0118	0.0583	CbGeAlD
Perhexiline—CPT2—gonad—ovarian cancer	0.0112	0.0553	CbGeAlD
Perhexiline—CPT2—uterus—ovarian cancer	0.0111	0.055	CbGeAlD
Perhexiline—CPT1A—female reproductive system—ovarian cancer	0.0105	0.0521	CbGeAlD
Perhexiline—Ataxia—Altretamine—ovarian cancer	0.0103	0.0347	CcSEcCtD
Perhexiline—CPT2—female reproductive system—ovarian cancer	0.00998	0.0494	CbGeAlD
Perhexiline—CPT1A—female gonad—ovarian cancer	0.00957	0.0474	CbGeAlD
Perhexiline—CPT1A—vagina—ovarian cancer	0.00951	0.0471	CbGeAlD
Perhexiline—CPT2—bone marrow—ovarian cancer	0.00942	0.0466	CbGeAlD
Perhexiline—CPT2—female gonad—ovarian cancer	0.00908	0.045	CbGeAlD
Perhexiline—CPT2—vagina—ovarian cancer	0.00903	0.0447	CbGeAlD
Perhexiline—CPT1A—testis—ovarian cancer	0.00849	0.042	CbGeAlD
Perhexiline—Polyneuropathy—Paclitaxel—ovarian cancer	0.00847	0.0284	CcSEcCtD
Perhexiline—Neuropathy peripheral—Altretamine—ovarian cancer	0.00831	0.0279	CcSEcCtD
Perhexiline—CPT2—testis—ovarian cancer	0.00806	0.0399	CbGeAlD
Perhexiline—Polyneuropathy—Docetaxel—ovarian cancer	0.00718	0.0241	CcSEcCtD
Perhexiline—CPT1A—lymph node—ovarian cancer	0.00615	0.0305	CbGeAlD
Perhexiline—CPT2—lymph node—ovarian cancer	0.00584	0.0289	CbGeAlD
Perhexiline—Convulsion—Altretamine—ovarian cancer	0.00574	0.0192	CcSEcCtD
Perhexiline—Cachexia—Epirubicin—ovarian cancer	0.00552	0.0185	CcSEcCtD
Perhexiline—Anorexia—Altretamine—ovarian cancer	0.00516	0.0173	CcSEcCtD
Perhexiline—Cachexia—Doxorubicin—ovarian cancer	0.00511	0.0171	CcSEcCtD
Perhexiline—Polyneuropathy—Epirubicin—ovarian cancer	0.00484	0.0162	CcSEcCtD
Perhexiline—Decreased appetite—Altretamine—ovarian cancer	0.0047	0.0158	CcSEcCtD
Perhexiline—Hepatocellular injury—Melphalan—ovarian cancer	0.0047	0.0157	CcSEcCtD
Perhexiline—Fatigue—Altretamine—ovarian cancer	0.00466	0.0156	CcSEcCtD
Perhexiline—Polyneuropathy—Doxorubicin—ovarian cancer	0.00448	0.015	CcSEcCtD
Perhexiline—Gait disturbance—Vinorelbine—ovarian cancer	0.0042	0.0141	CcSEcCtD
Perhexiline—Asthenia—Altretamine—ovarian cancer	0.00388	0.013	CcSEcCtD
Perhexiline—Ataxia—Chlorambucil—ovarian cancer	0.00368	0.0123	CcSEcCtD
Perhexiline—Dizziness—Altretamine—ovarian cancer	0.00358	0.012	CcSEcCtD
Perhexiline—Vomiting—Altretamine—ovarian cancer	0.00344	0.0115	CcSEcCtD
Perhexiline—Nausea—Altretamine—ovarian cancer	0.00321	0.0108	CcSEcCtD
Perhexiline—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00295	0.0099	CcSEcCtD
Perhexiline—CYP2B6—gonad—ovarian cancer	0.00291	0.0144	CbGeAlD
Perhexiline—Gait disturbance—Paclitaxel—ovarian cancer	0.00283	0.00948	CcSEcCtD
Perhexiline—Neuropathy peripheral—Topotecan—ovarian cancer	0.00263	0.00882	CcSEcCtD
Perhexiline—Muscular weakness—Vinorelbine—ovarian cancer	0.00263	0.0088	CcSEcCtD
Perhexiline—CYP2B6—female reproductive system—ovarian cancer	0.0026	0.0129	CbGeAlD
Perhexiline—Neuropathy peripheral—Melphalan—ovarian cancer	0.00257	0.00863	CcSEcCtD
Perhexiline—Sweating—Topotecan—ovarian cancer	0.00257	0.00862	CcSEcCtD
Perhexiline—Optic neuritis—Epirubicin—ovarian cancer	0.00256	0.0086	CcSEcCtD
Perhexiline—Optic neuritis—Doxorubicin—ovarian cancer	0.00237	0.00795	CcSEcCtD
Perhexiline—Hepatitis—Melphalan—ovarian cancer	0.00236	0.0079	CcSEcCtD
Perhexiline—CYP2B6—vagina—ovarian cancer	0.00235	0.0116	CbGeAlD
Perhexiline—Hepatocellular injury—Docetaxel—ovarian cancer	0.00234	0.00784	CcSEcCtD
Perhexiline—Weight decreased—Vinorelbine—ovarian cancer	0.00233	0.00781	CcSEcCtD
Perhexiline—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00225	0.00754	CcSEcCtD
Perhexiline—Tremor—Chlorambucil—ovarian cancer	0.00221	0.0074	CcSEcCtD
Perhexiline—Flushing—Melphalan—ovarian cancer	0.00219	0.00734	CcSEcCtD
Perhexiline—CYP2B6—testis—ovarian cancer	0.0021	0.0104	CbGeAlD
Perhexiline—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00205	0.00688	CcSEcCtD
Perhexiline—Convulsion—Chlorambucil—ovarian cancer	0.00204	0.00684	CcSEcCtD
Perhexiline—CYP3A4—female reproductive system—ovarian cancer	0.00196	0.00971	CbGeAlD
Perhexiline—CYP2D6—female reproductive system—ovarian cancer	0.00193	0.00955	CbGeAlD
Perhexiline—Flushing—Vinorelbine—ovarian cancer	0.00191	0.00641	CcSEcCtD
Perhexiline—Ataxia—Paclitaxel—ovarian cancer	0.00188	0.00631	CcSEcCtD
Perhexiline—Liver injury—Epirubicin—ovarian cancer	0.00187	0.00628	CcSEcCtD
Perhexiline—Anorexia—Chlorambucil—ovarian cancer	0.00183	0.00614	CcSEcCtD
Perhexiline—Convulsion—Melphalan—ovarian cancer	0.00178	0.00596	CcSEcCtD
Perhexiline—Muscular weakness—Paclitaxel—ovarian cancer	0.00177	0.00592	CcSEcCtD
Perhexiline—CYP2D6—female gonad—ovarian cancer	0.00176	0.00869	CbGeAlD
Perhexiline—CPT2—PPARA activates gene expression—YAP1—ovarian cancer	0.00174	0.0359	CbGpPWpGaD
Perhexiline—Liver injury—Doxorubicin—ovarian cancer	0.00173	0.00582	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—ovarian cancer	0.0017	0.0352	CbGpPWpGaD
Perhexiline—Decreased appetite—Chlorambucil—ovarian cancer	0.00167	0.0056	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—CCND1—ovarian cancer	0.00167	0.0345	CbGpPWpGaD
Perhexiline—Fatigue—Chlorambucil—ovarian cancer	0.00166	0.00555	CcSEcCtD
Perhexiline—Hyperhidrosis—Topotecan—ovarian cancer	0.00165	0.00554	CcSEcCtD
Perhexiline—Anorexia—Topotecan—ovarian cancer	0.00163	0.00547	CcSEcCtD
Perhexiline—Gait disturbance—Epirubicin—ovarian cancer	0.00162	0.00542	CcSEcCtD
Perhexiline—Anorexia—Melphalan—ovarian cancer	0.0016	0.00535	CcSEcCtD
Perhexiline—Ataxia—Docetaxel—ovarian cancer	0.0016	0.00535	CcSEcCtD
Perhexiline—CYP2B6—Liver X Receptor Pathway—FASN—ovarian cancer	0.00158	0.0327	CbGpPWpGaD
Perhexiline—Hepatocellular injury—Epirubicin—ovarian cancer	0.00158	0.00529	CcSEcCtD
Perhexiline—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00157	0.00527	CcSEcCtD
Perhexiline—Weight decreased—Paclitaxel—ovarian cancer	0.00157	0.00525	CcSEcCtD
Perhexiline—CYP2D6—testis—ovarian cancer	0.00156	0.00771	CbGeAlD
Perhexiline—Paraesthesia—Topotecan—ovarian cancer	0.00154	0.00515	CcSEcCtD
Perhexiline—Urticaria—Chlorambucil—ovarian cancer	0.00153	0.00512	CcSEcCtD
Perhexiline—Abdominal pain—Chlorambucil—ovarian cancer	0.00152	0.00509	CcSEcCtD
Perhexiline—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00151	0.00507	CcSEcCtD
Perhexiline—Paraesthesia—Melphalan—ovarian cancer	0.0015	0.00504	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—ovarian cancer	0.0015	0.00501	CcSEcCtD
Perhexiline—Decreased appetite—Topotecan—ovarian cancer	0.00149	0.00499	CcSEcCtD
Perhexiline—Fatigue—Topotecan—ovarian cancer	0.00148	0.00495	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—ovarian cancer	0.00146	0.00489	CcSEcCtD
Perhexiline—Decreased appetite—Melphalan—ovarian cancer	0.00146	0.00488	CcSEcCtD
Perhexiline—Fatigue—Melphalan—ovarian cancer	0.00144	0.00484	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—FASN—ovarian cancer	0.00143	0.0295	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Topotecan—ovarian cancer	0.0014	0.00469	CcSEcCtD
Perhexiline—Anorexia—Vinorelbine—ovarian cancer	0.0014	0.00468	CcSEcCtD
Perhexiline—Asthenia—Chlorambucil—ovarian cancer	0.00138	0.00462	CcSEcCtD
Perhexiline—Urticaria—Topotecan—ovarian cancer	0.00136	0.00456	CcSEcCtD
Perhexiline—Abdominal pain—Topotecan—ovarian cancer	0.00135	0.00453	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—MYC—ovarian cancer	0.00134	0.0276	CbGpPWpGaD
Perhexiline—Urticaria—Melphalan—ovarian cancer	0.00133	0.00446	CcSEcCtD
Perhexiline—Weight decreased—Docetaxel—ovarian cancer	0.00133	0.00445	CcSEcCtD
Perhexiline—Paraesthesia—Vinorelbine—ovarian cancer	0.00131	0.00441	CcSEcCtD
Perhexiline—Flushing—Paclitaxel—ovarian cancer	0.00129	0.00431	CcSEcCtD
Perhexiline—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00128	0.0043	CcSEcCtD
Perhexiline—Decreased appetite—Vinorelbine—ovarian cancer	0.00127	0.00427	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—TOP1—ovarian cancer	0.00127	0.0262	CbGpPWpGaD
Perhexiline—Fatigue—Vinorelbine—ovarian cancer	0.00126	0.00423	CcSEcCtD
Perhexiline—Asthenia—Topotecan—ovarian cancer	0.00123	0.00412	CcSEcCtD
Perhexiline—Vomiting—Chlorambucil—ovarian cancer	0.00122	0.0041	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—YAP1—ovarian cancer	0.00121	0.0249	CbGpPWpGaD
Perhexiline—Asthenia—Melphalan—ovarian cancer	0.0012	0.00403	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.0012	0.00401	CcSEcCtD
Perhexiline—Tension—Paclitaxel—ovarian cancer	0.00118	0.00397	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—ovarian cancer	0.00118	0.0244	CbGpPWpGaD
Perhexiline—Hepatitis—Docetaxel—ovarian cancer	0.00117	0.00394	CcSEcCtD
Perhexiline—Hypoglycaemia—Epirubicin—ovarian cancer	0.00117	0.00393	CcSEcCtD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	0.00117	0.0242	CbGpPWpGaD
Perhexiline—Nervousness—Paclitaxel—ovarian cancer	0.00117	0.00393	CcSEcCtD
Perhexiline—Urticaria—Vinorelbine—ovarian cancer	0.00116	0.0039	CcSEcCtD
Perhexiline—Abdominal pain—Vinorelbine—ovarian cancer	0.00116	0.00388	CcSEcCtD
Perhexiline—CPT1A—PPAR Alpha Pathway—CCND1—ovarian cancer	0.00116	0.0239	CbGpPWpGaD
Perhexiline—Diplopia—Epirubicin—ovarian cancer	0.00115	0.00384	CcSEcCtD
Perhexiline—Nausea—Chlorambucil—ovarian cancer	0.00114	0.00383	CcSEcCtD
Perhexiline—Dizziness—Topotecan—ovarian cancer	0.00113	0.00379	CcSEcCtD
Perhexiline—Tremor—Paclitaxel—ovarian cancer	0.00113	0.00379	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—PPP1CC—ovarian cancer	0.00111	0.0229	CbGpPWpGaD
Perhexiline—Flushing—Docetaxel—ovarian cancer	0.00109	0.00365	CcSEcCtD
Perhexiline—Vomiting—Topotecan—ovarian cancer	0.00109	0.00365	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00109	0.00364	CcSEcCtD
Perhexiline—Syncope—Paclitaxel—ovarian cancer	0.00108	0.00363	CcSEcCtD
Perhexiline—Rash—Topotecan—ovarian cancer	0.00108	0.00362	CcSEcCtD
Perhexiline—Dermatitis—Topotecan—ovarian cancer	0.00108	0.00361	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—ovarian cancer	0.00108	0.00361	CcSEcCtD
Perhexiline—Headache—Topotecan—ovarian cancer	0.00107	0.00359	CcSEcCtD
Perhexiline—Vomiting—Melphalan—ovarian cancer	0.00107	0.00357	CcSEcCtD
Perhexiline—Loss of consciousness—Paclitaxel—ovarian cancer	0.00106	0.00355	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—ovarian cancer	0.00106	0.00355	CcSEcCtD
Perhexiline—Rash—Melphalan—ovarian cancer	0.00106	0.00354	CcSEcCtD
Perhexiline—Dermatitis—Melphalan—ovarian cancer	0.00106	0.00354	CcSEcCtD
Perhexiline—Asthenia—Vinorelbine—ovarian cancer	0.00105	0.00352	CcSEcCtD
Perhexiline—Convulsion—Paclitaxel—ovarian cancer	0.00105	0.0035	CcSEcCtD
Perhexiline—Nausea—Topotecan—ovarian cancer	0.00102	0.00341	CcSEcCtD
Perhexiline—Muscular weakness—Epirubicin—ovarian cancer	0.00101	0.00339	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—ovarian cancer	0.000996	0.00334	CcSEcCtD
Perhexiline—Nausea—Melphalan—ovarian cancer	0.000995	0.00334	CcSEcCtD
Perhexiline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000987	0.0204	CbGpPWpGaD
Perhexiline—Shock—Paclitaxel—ovarian cancer	0.000969	0.00325	CcSEcCtD
Perhexiline—Dizziness—Vinorelbine—ovarian cancer	0.000968	0.00324	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—HNF1B—ovarian cancer	0.000962	0.0199	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	0.000956	0.0198	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000952	0.00319	CcSEcCtD
Perhexiline—Anorexia—Paclitaxel—ovarian cancer	0.000938	0.00315	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—ovarian cancer	0.000935	0.00313	CcSEcCtD
Perhexiline—Vomiting—Vinorelbine—ovarian cancer	0.000931	0.00312	CcSEcCtD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—ovarian cancer	0.000927	0.0192	CbGpPWpGaD
Perhexiline—Rash—Vinorelbine—ovarian cancer	0.000923	0.00309	CcSEcCtD
Perhexiline—Dermatitis—Vinorelbine—ovarian cancer	0.000922	0.00309	CcSEcCtD
Perhexiline—Headache—Vinorelbine—ovarian cancer	0.000917	0.00307	CcSEcCtD
Perhexiline—Syncope—Docetaxel—ovarian cancer	0.000917	0.00307	CcSEcCtD
Perhexiline—Loss of consciousness—Docetaxel—ovarian cancer	0.000899	0.00301	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—ovarian cancer	0.000895	0.003	CcSEcCtD
Perhexiline—Insomnia—Paclitaxel—ovarian cancer	0.00089	0.00298	CcSEcCtD
Perhexiline—Convulsion—Docetaxel—ovarian cancer	0.000886	0.00297	CcSEcCtD
Perhexiline—Paraesthesia—Paclitaxel—ovarian cancer	0.000884	0.00296	CcSEcCtD
Perhexiline—Nausea—Vinorelbine—ovarian cancer	0.000869	0.00291	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000865	0.0029	CcSEcCtD
Perhexiline—Decreased appetite—Paclitaxel—ovarian cancer	0.000856	0.00287	CcSEcCtD
Perhexiline—Fatigue—Paclitaxel—ovarian cancer	0.000849	0.00285	CcSEcCtD
Perhexiline—Sweating—Epirubicin—ovarian cancer	0.000846	0.00284	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—ovarian cancer	0.000829	0.00278	CcSEcCtD
Perhexiline—Shock—Docetaxel—ovarian cancer	0.000821	0.00275	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	0.000813	0.0168	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000805	0.0027	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.0008	0.00268	CcSEcCtD
Perhexiline—Anorexia—Docetaxel—ovarian cancer	0.000795	0.00267	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—ovarian cancer	0.000792	0.00266	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—ovarian cancer	0.000783	0.00262	CcSEcCtD
Perhexiline—Urticaria—Paclitaxel—ovarian cancer	0.000782	0.00262	CcSEcCtD
Perhexiline—Abdominal pain—Paclitaxel—ovarian cancer	0.000778	0.00261	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—PIK3CG—ovarian cancer	0.000771	0.0159	CbGpPWpGaD
Perhexiline—Insomnia—Docetaxel—ovarian cancer	0.000755	0.00253	CcSEcCtD
Perhexiline—Paraesthesia—Docetaxel—ovarian cancer	0.000749	0.00251	CcSEcCtD
Perhexiline—Flushing—Epirubicin—ovarian cancer	0.000735	0.00246	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—ovarian cancer	0.000733	0.00246	CcSEcCtD
Perhexiline—Decreased appetite—Docetaxel—ovarian cancer	0.000725	0.00243	CcSEcCtD
Perhexiline—Fatigue—Docetaxel—ovarian cancer	0.000719	0.00241	CcSEcCtD
Perhexiline—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000719	0.0149	CbGpPWpGaD
Perhexiline—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000713	0.0147	CbGpPWpGaD
Perhexiline—Asthenia—Paclitaxel—ovarian cancer	0.000706	0.00237	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000696	0.0144	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000682	0.00229	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—ovarian cancer	0.00068	0.00228	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—PIK3CD—ovarian cancer	0.000678	0.014	CbGpPWpGaD
Perhexiline—Tension—Epirubicin—ovarian cancer	0.000677	0.00227	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—ovarian cancer	0.00067	0.00225	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	0.000663	0.0137	CbGpPWpGaD
Perhexiline—Abdominal pain—Docetaxel—ovarian cancer	0.00066	0.00221	CcSEcCtD
Perhexiline—Dizziness—Paclitaxel—ovarian cancer	0.000651	0.00218	CcSEcCtD
Perhexiline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000645	0.0133	CbGpPWpGaD
Perhexiline—Tension—Doxorubicin—ovarian cancer	0.000626	0.0021	CcSEcCtD
Perhexiline—Vomiting—Paclitaxel—ovarian cancer	0.000626	0.0021	CcSEcCtD
Perhexiline—Rash—Paclitaxel—ovarian cancer	0.000621	0.00208	CcSEcCtD
Perhexiline—Dermatitis—Paclitaxel—ovarian cancer	0.00062	0.00208	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—ovarian cancer	0.00062	0.00208	CcSEcCtD
Perhexiline—Syncope—Epirubicin—ovarian cancer	0.000618	0.00207	CcSEcCtD
Perhexiline—Headache—Paclitaxel—ovarian cancer	0.000617	0.00207	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—ovarian cancer	0.000606	0.00203	CcSEcCtD
Perhexiline—Asthenia—Docetaxel—ovarian cancer	0.000599	0.00201	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—ovarian cancer	0.000598	0.002	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—MTOR—ovarian cancer	0.000591	0.0122	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CB—ovarian cancer	0.000591	0.0122	CbGpPWpGaD
Perhexiline—Nausea—Paclitaxel—ovarian cancer	0.000585	0.00196	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—ovarian cancer	0.000572	0.00192	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—ovarian cancer	0.000561	0.00188	CcSEcCtD
Perhexiline—Shock—Epirubicin—ovarian cancer	0.000554	0.00186	CcSEcCtD
Perhexiline—CYP2D6—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000554	0.0114	CbGpPWpGaD
Perhexiline—Convulsion—Doxorubicin—ovarian cancer	0.000553	0.00185	CcSEcCtD
Perhexiline—Dizziness—Docetaxel—ovarian cancer	0.000552	0.00185	CcSEcCtD
Perhexiline—CPT2—Metabolism—NME2—ovarian cancer	0.00055	0.0114	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Epirubicin—ovarian cancer	0.000544	0.00182	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—ovarian cancer	0.000537	0.0018	CcSEcCtD
Perhexiline—Vomiting—Docetaxel—ovarian cancer	0.000531	0.00178	CcSEcCtD
Perhexiline—Rash—Docetaxel—ovarian cancer	0.000526	0.00176	CcSEcCtD
Perhexiline—Dermatitis—Docetaxel—ovarian cancer	0.000526	0.00176	CcSEcCtD
Perhexiline—Headache—Docetaxel—ovarian cancer	0.000523	0.00175	CcSEcCtD
Perhexiline—Shock—Doxorubicin—ovarian cancer	0.000512	0.00172	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—ovarian cancer	0.000509	0.00171	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—ovarian cancer	0.000505	0.00169	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000503	0.00169	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—ovarian cancer	0.000496	0.00166	CcSEcCtD
Perhexiline—Nausea—Docetaxel—ovarian cancer	0.000496	0.00166	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—ovarian cancer	0.000489	0.00164	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—ovarian cancer	0.000485	0.00163	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000483	0.00998	CbGpPWpGaD
Perhexiline—Insomnia—Doxorubicin—ovarian cancer	0.000471	0.00158	CcSEcCtD
Perhexiline—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000468	0.00968	CbGpPWpGaD
Perhexiline—Paraesthesia—Doxorubicin—ovarian cancer	0.000468	0.00157	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000467	0.00965	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00046	0.00154	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—ovarian cancer	0.000453	0.00152	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—ovarian cancer	0.000449	0.00151	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—ovarian cancer	0.000447	0.0015	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—TYMS—ovarian cancer	0.000447	0.00924	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000446	0.00922	CbGpPWpGaD
Perhexiline—Abdominal pain—Epirubicin—ovarian cancer	0.000445	0.00149	CcSEcCtD
Perhexiline—CYP2D6—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000428	0.00884	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000426	0.00143	CcSEcCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000422	0.00872	CbGpPWpGaD
Perhexiline—Urticaria—Doxorubicin—ovarian cancer	0.000414	0.00139	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—ovarian cancer	0.000412	0.00138	CcSEcCtD
Perhexiline—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000409	0.00846	CbGpPWpGaD
Perhexiline—Asthenia—Epirubicin—ovarian cancer	0.000404	0.00135	CcSEcCtD
Perhexiline—CPT1A—Metabolism—NME2—ovarian cancer	0.000382	0.00789	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000381	0.00787	CbGpPWpGaD
Perhexiline—Asthenia—Doxorubicin—ovarian cancer	0.000374	0.00125	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—ovarian cancer	0.000372	0.00125	CcSEcCtD
Perhexiline—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000362	0.00748	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CA—ovarian cancer	0.00036	0.00745	CbGpPWpGaD
Perhexiline—Vomiting—Epirubicin—ovarian cancer	0.000358	0.0012	CcSEcCtD
Perhexiline—Rash—Epirubicin—ovarian cancer	0.000355	0.00119	CcSEcCtD
Perhexiline—CPT2—Metabolism—CYTB—ovarian cancer	0.000355	0.00733	CbGpPWpGaD
Perhexiline—Dermatitis—Epirubicin—ovarian cancer	0.000355	0.00119	CcSEcCtD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000353	0.0073	CbGpPWpGaD
Perhexiline—Headache—Epirubicin—ovarian cancer	0.000353	0.00118	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—TP53—ovarian cancer	0.000349	0.00721	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000347	0.00717	CbGpPWpGaD
Perhexiline—Dizziness—Doxorubicin—ovarian cancer	0.000344	0.00115	CcSEcCtD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000344	0.00711	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000339	0.00702	CbGpPWpGaD
Perhexiline—Nausea—Epirubicin—ovarian cancer	0.000334	0.00112	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—ovarian cancer	0.000331	0.00111	CcSEcCtD
Perhexiline—Rash—Doxorubicin—ovarian cancer	0.000328	0.0011	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—ovarian cancer	0.000328	0.0011	CcSEcCtD
Perhexiline—Headache—Doxorubicin—ovarian cancer	0.000326	0.00109	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000324	0.00669	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPP1CC—ovarian cancer	0.00031	0.00641	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—BRIP1—ovarian cancer	0.00031	0.00641	CbGpPWpGaD
Perhexiline—Nausea—Doxorubicin—ovarian cancer	0.000309	0.00104	CcSEcCtD
Perhexiline—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000297	0.00614	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000296	0.00611	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT1—ovarian cancer	0.000294	0.00609	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000283	0.00585	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000279	0.00576	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000273	0.00564	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000264	0.00545	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYTB—ovarian cancer	0.000246	0.00508	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00024	0.00497	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.00024	0.00497	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000239	0.00494	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000236	0.00488	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000226	0.00467	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PTEN—ovarian cancer	0.000217	0.00449	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—BRIP1—ovarian cancer	0.000215	0.00444	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPP1CC—ovarian cancer	0.000215	0.00444	CbGpPWpGaD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000213	0.0044	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—YAP1—ovarian cancer	0.000208	0.0043	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000206	0.00425	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000203	0.00419	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000194	0.00401	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000193	0.004	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000181	0.00374	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—FASN—ovarian cancer	0.00017	0.0035	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC5A5—ovarian cancer	0.000167	0.00345	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000166	0.00343	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC2A1—ovarian cancer	0.000161	0.00333	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000158	0.00326	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000157	0.00324	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000156	0.00323	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP1B1—ovarian cancer	0.000154	0.00319	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000154	0.00319	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—ovarian cancer	0.000148	0.00306	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	0.000148	0.00306	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000146	0.00302	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—YAP1—ovarian cancer	0.000144	0.00298	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000143	0.00295	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPP2R1A—ovarian cancer	0.000137	0.00283	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000136	0.00282	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—IL6—ovarian cancer	0.000136	0.0028	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ABCB1—ovarian cancer	0.000127	0.00263	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000127	0.00262	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000125	0.00259	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TYMS—ovarian cancer	0.000125	0.00258	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—FASN—ovarian cancer	0.000117	0.00243	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC5A5—ovarian cancer	0.000116	0.00239	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC2A1—ovarian cancer	0.000112	0.00231	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000109	0.00226	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP1B1—ovarian cancer	0.000107	0.00221	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000103	0.00213	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000102	0.0021	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CAV1—ovarian cancer	0.000101	0.00208	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.61e-05	0.00199	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPP2R1A—ovarian cancer	9.49e-05	0.00196	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.44e-05	0.00195	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CG—ovarian cancer	9.16e-05	0.00189	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NME2—ovarian cancer	9.03e-05	0.00187	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—ovarian cancer	8.81e-05	0.00182	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TYMS—ovarian cancer	8.65e-05	0.00179	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CD—ovarian cancer	8.06e-05	0.00167	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CB—ovarian cancer	7.02e-05	0.00145	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CAV1—ovarian cancer	6.97e-05	0.00144	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.73e-05	0.00139	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.66e-05	0.00138	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.64e-05	0.00137	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CG—ovarian cancer	6.35e-05	0.00131	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NME2—ovarian cancer	6.27e-05	0.0013	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—ovarian cancer	6.07e-05	0.00125	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYTB—ovarian cancer	5.82e-05	0.0012	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CD—ovarian cancer	5.58e-05	0.00115	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BRIP1—ovarian cancer	5.09e-05	0.00105	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPP1CC—ovarian cancer	5.09e-05	0.00105	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CB—ovarian cancer	4.87e-05	0.00101	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—ovarian cancer	4.28e-05	0.000885	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—ovarian cancer	4.21e-05	0.00087	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NME2—ovarian cancer	4.1e-05	0.000848	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYTB—ovarian cancer	4.04e-05	0.000836	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPP1CC—ovarian cancer	3.53e-05	0.000731	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BRIP1—ovarian cancer	3.53e-05	0.000731	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—ovarian cancer	3.5e-05	0.000723	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—YAP1—ovarian cancer	3.41e-05	0.000705	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—ovarian cancer	2.97e-05	0.000614	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FASN—ovarian cancer	2.78e-05	0.000575	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC5A5—ovarian cancer	2.73e-05	0.000565	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYTB—ovarian cancer	2.64e-05	0.000547	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC2A1—ovarian cancer	2.64e-05	0.000546	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1B1—ovarian cancer	2.53e-05	0.000524	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—ovarian cancer	2.42e-05	0.000501	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—YAP1—ovarian cancer	2.37e-05	0.00049	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.31e-05	0.000478	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.31e-05	0.000478	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	2.25e-05	0.000464	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—ovarian cancer	2.09e-05	0.000431	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMS—ovarian cancer	2.05e-05	0.000423	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FASN—ovarian cancer	1.93e-05	0.0004	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.9e-05	0.000393	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.84e-05	0.00038	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.76e-05	0.000364	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CAV1—ovarian cancer	1.65e-05	0.000341	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.56e-05	0.000323	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—YAP1—ovarian cancer	1.55e-05	0.00032	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.5e-05	0.000311	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.45e-05	0.0003	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMS—ovarian cancer	1.42e-05	0.000294	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.32e-05	0.000273	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—FASN—ovarian cancer	1.26e-05	0.000261	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.24e-05	0.000257	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.2e-05	0.000248	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.15e-05	0.000238	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.15e-05	0.000238	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CAV1—ovarian cancer	1.15e-05	0.000237	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.04e-05	0.000216	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.02e-05	0.000211	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—ovarian cancer	9.95e-06	0.000206	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—ovarian cancer	9.48e-06	0.000196	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMS—ovarian cancer	9.31e-06	0.000192	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CD—ovarian cancer	9.18e-06	0.00019	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CB—ovarian cancer	8.01e-06	0.000166	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CAV1—ovarian cancer	7.5e-06	0.000155	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—ovarian cancer	7.02e-06	0.000145	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—ovarian cancer	6.92e-06	0.000143	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.83e-06	0.000141	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6e-06	0.000124	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—ovarian cancer	5.74e-06	0.000119	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.23e-06	0.000108	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—ovarian cancer	4.88e-06	0.000101	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—ovarian cancer	4.52e-06	9.35e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—ovarian cancer	3.99e-06	8.24e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.19e-06	6.6e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—ovarian cancer	2.61e-06	5.39e-05	CbGpPWpGaD
